StockDuty ← Dashboard Nov 11, 2026 03:01 AM ET
SignalFDA/Bio

Capricor outlines 2027 manufacturing validation as Deramiocel BLA heads toward Nov. 22 PDUFA date

Capricor cites 2027 manufacturing validation ahead of Deramiocel BLA's Nov. 22 PDUFA date.

What changed
Capricor cites 2027 manufacturing validation ahead of Deramiocel BLA's Nov. 22 PDUFA date.
Why it matters
Capricor cites 2027 manufacturing validation ahead of Deramiocel BLA's Nov. 22 PDUFA date. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →